DENVER, March 08, 2017 -- Global CBD cannabis innovator Elixinol has announced the launch of Respira, a versatile, full-spectrum cannabidiol (CBD) tincture line.
Photos accompanying this announcement are available at
http://www.globenewswire.com/NewsRoom/AttachmentNg/802dcf21-081a-4a7a-8b3f-0296cd7f69e6
http://www.globenewswire.com/NewsRoom/AttachmentNg/3c75f9df-ec94-4722-a0f9-5645e457d5bd
http://www.globenewswire.com/NewsRoom/AttachmentNg/65cb132e-206e-47e4-8f54-42bbcd1c3b4d
http://www.globenewswire.com/NewsRoom/AttachmentNg/cfa76333-fc69-49d1-9e69-75a688e06670
Elixinol has developed Respira with all natural ingredients, making Respira a multi-purpose CBD product suitable for consumption orally, topically, or by vape.
As CBD gains in popularity as a cannabis product without psychoactive properties, consumers are seeking ways to incorporate CBD into their daily lives including topical, digestive and vape oil.
“Respira is our most versatile tincture to date, the customer has complete control over the delivery mechanisms,” said Chris Husong, Director of Marketing and Sales of Elixinol. “As cannabis and CBD customers become more educated, we will continue to develop convenient, high-quality products designed for how our customers are using CBD today.”
Each 10 mg serving size of Respira delivers high concentrations of either 300 mg or 600 mg of CBD oil. Respira is sold in two refreshing flavors, grape-mint and natural.
“I use Respira to ease anxiety, pain and headaches associated with my chronic traumatic encephalopathy (CTE). I can use this as a vape oil in my vape pen when I’m on the go,” said CBD advocate and New York Giants Super Bowl champion Leonard Marshall. “This is a product formulated for busy people like me, and it allows me to be my best me.”
About Elixinol:
Colorado-based Elixinol, founded by Paul Benhaim, hemp entrepreneur since 1991, is widely regarded as one of the most influential CBD brands in the world. With a proven track record of growing and manufacturing high-quality hemp, Elixinol also conducts rigorous laboratory testing and quality control. A global leader in hemp distribution, Elixinol distributes CBD products globally in the United States, Japan, Puerto Rico and the UK. More information is available at Elixinol.com.
Media Contact: Chris Husong Elixinol 844-804-3504 ext 420 [email protected]


TSMC Eyes 3nm Chip Production in Japan with $17 Billion Kumamoto Investment
SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns
Trump Backs Nexstar–Tegna Merger Amid Shifting U.S. Media Landscape
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns
Washington Post Publisher Will Lewis Steps Down After Layoffs
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing
Tencent Shares Slide After WeChat Restricts YuanBao AI Promotional Links
Instagram Outage Disrupts Thousands of U.S. Users
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off
Baidu Approves $5 Billion Share Buyback and Plans First-Ever Dividend in 2026
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million
CK Hutchison Launches Arbitration After Panama Court Revokes Canal Port Licences 



